Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-6581-01
Dosage Form
Injection
Presentation
Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 250 mg/50 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-6581-01)
Initial Posting
Feb 20, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.